Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07592728 · ClinicalTrials.gov registry record · NA
Brief Inhibitory Training for Eating - Intervention
A NA study, sponsored by George Mason University.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT07592728: Recruiting NA study, sponsored by George Mason University.
NCT07592728 is a NA study that is actively recruiting participants, run by George Mason University. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07592728, a NA study, is actively recruiting participants, sponsored by George Mason University.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation. In the study, participants will: Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone
Primary Outcome
Go-No/Go Task with food cues
Interventions
- BEHAVIORAL Daily inhibitory control training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-03-10 |
| Phase | NA |
What NCT07592728 shows while recruiting
NCT07592728 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Daily inhibitory control training is the first listed.
NCT07592728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07592728 about?
NCT07592728 is a clinical study titled "Brief Inhibitory Training for Eating - Intervention". The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Aim 2 is to evaluate the efficacy of IC training for modifying the h...
What is the current status of trial NCT07592728?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2026-05-01. Estimated completion is 2027-03-10.
What interventions are being tested in trial NCT07592728?
The interventions under investigation include: Daily inhibitory control training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07592728?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07592728's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI